Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FRA10A associated CGG repeat 1 (FRA10AC1) encodes a nuclear phosphoprotein of unknown function in humans. The gene is notable for containing a tandem CGG repeat in its 5' untranslated region (UTR), located within a folate-sensitive fragile site on chromosome 10 (fra(10)(q23.3)). These CGG repeat tracts can normally range from 8 to 14 units, occasionally expanding to >200 repeats, leading to hypermethylation and transcriptional silencing. However, unlike other repeat expansion disorders, no direct disease phenotype has been conclusively associated with expansion of the CGG repeat in FRA10AC1. The protein product is classified as a nuclear phosphoprotein, but its precise biological role and possible involvement in pathogenesis remain unclear. The gene is sometimes referenced in the context of CGG repeat expansion research because of its similarity to other repeat loci that are implicated in neurological disorders, but it is not currently considered a druggable or therapeutic target.
no known mechanism as a drug target; approaches that target CGG repeat expansions involve antisense oligonucleotides, RNA interference, and small molecule binding, generally not proven for this specific locus
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FRA10A associated CGG repeat 1 (FRA10AC1).